Gilead Alberta, a fully integrated research and manufacturing facility of Gilead Sciences Canada, has announced a $47 million expansion of its research and manufacturing facility in Edmonton, Alberta. The expansion will create more than 80 full-time positions at Gilead Alberta and increase the size of the facility by 45,000 square feet to create new laboratory and research space. 

The Edmonton site develops and manufactures Gilead's investigational medicines for clinical research programs in hepatitis C, HIV/AIDS and cancer. In 2012, the company spent almost $55 million dollars in R&D in Canada, and most of this investment was targeted to Alberta. There currently are more than 250 staff working at the Edmonton site in R&D, analytical research, drug manufacturing and quality assurance.